A multicenter adaptive prospective randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge (ACTIV-4C)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Covid-19
-
Age: Between 18 years - 110 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Participants who are PCR-positive COVID-19 infection
- Hospitalized for 48 or more hours
- Participants who will provide written consent form
You may not be eligible for this study if the following are true:
-
- Existing indication for anticoagulation, either therapeutic or prophylactic dose
- Contraindication to antithrombotic therapy
- Pregnant
- Prison inmate
- Life expectancy less than 90 days
- Unwilling or unable to provide informed consent / unwilling or unable to complete the study protocol
- Other criteria related to arm-specific appendices developed as adaptations to the trial
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.